NeuroOne Medical Technologies Corporation Research and Development Expense
NeuroOne Medical Technologies Corporation (NMTC) reported Research and Development Expense of $1.43 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-13
- NeuroOne Medical Technologies Corporation research and development expense for the quarter ending 2026-06-30 was $1.43M, a 20.52% increase year-over-year.
- NeuroOne Medical Technologies Corporation research and development expense for the quarter ending 2026-03-31 was $1.47M, a 2.82% decline year-over-year.
- NeuroOne Medical Technologies Corporation research and development expense for the quarter ending 2025-12-31 was $1.39M, a 18.55% increase year-over-year.
- NeuroOne Medical Technologies Corporation research and development expense for the quarter ending 2025-09-30 was $1.12M, a 0.39% increase year-over-year.
- NeuroOne Medical Technologies Corporation research and development expense for fiscal 2025 was $4.98M, a 1.62% decline from fiscal 2024.
- NeuroOne Medical Technologies Corporation research and development expense for fiscal 2024 was $5.07M, a 27.02% decline from fiscal 2023.
- NeuroOne Medical Technologies Corporation research and development expense for fiscal 2023 was $6.94M, a 40.80% increase from fiscal 2022.
- NeuroOne Medical Technologies Corporation research and development expense for fiscal 2022 was $4.93M, a 25.59% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.43M 10-Q · filed 2026-08-13 | $2.89M derived: sum of 2 quarters · filed 2026-08-13 | $4.28M 10-Q · filed 2026-08-13 | $5.40M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $1.47M 10-Q/A · filed 2026-06-12 | $2.86M 10-Q/A · filed 2026-06-12 | $3.98M derived: sum of 3 quarters · filed 2026-06-12 | $5.16M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $1.39M 10-Q · filed 2026-02-17 | $2.51M derived: sum of 2 quarters · filed 2026-02-17 | $3.69M derived: sum of 3 quarters · filed 2026-08-13 | $5.20M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-09-30 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | $2.30M derived: sum of 2 quarters · filed 2026-08-13 | $3.81M derived: sum of 3 quarters · filed 2026-08-13 | $4.98M 10-K · filed 2025-12-17 |
| 2025-06-30 | $1.18M 10-Q · filed 2026-08-13 | $2.69M derived: sum of 2 quarters · filed 2026-08-13 | $3.87M 10-Q · filed 2026-08-13 | $4.98M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $1.51M 10-Q/A · filed 2026-06-12 | $2.68M 10-Q/A · filed 2026-06-12 | $3.80M derived: sum of 3 quarters · filed 2026-06-12 | $4.99M derived: sum of 4 quarters · filed 2026-06-12 |
| 2024-12-31 | $1.17M 10-Q · filed 2026-02-17 | $2.29M derived: sum of 2 quarters · filed 2026-02-17 | $3.48M derived: sum of 3 quarters · filed 2026-02-17 | $4.75M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-09-30 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | $2.31M derived: sum of 2 quarters · filed 2025-12-17 | $3.58M derived: sum of 3 quarters · filed 2025-12-17 | $5.07M 10-K · filed 2025-12-17 |
| 2024-06-30 | $1.19M 10-Q · filed 2025-08-14 | $2.47M derived: sum of 2 quarters · filed 2025-08-14 | $3.95M 10-Q · filed 2025-08-14 | $5.73M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $1.27M 10-Q · filed 2025-05-13 | $2.76M 10-Q · filed 2025-05-13 | $4.54M derived: sum of 3 quarters · filed 2025-05-13 | $6.43M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $1.48M 10-Q · filed 2025-02-12 | $3.26M derived: sum of 2 quarters · filed 2025-02-12 | $5.15M derived: sum of 3 quarters · filed 2025-02-12 | $6.86M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-09-30 | $1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-17 | $3.67M derived: sum of 2 quarters · filed 2024-12-17 | $5.38M derived: sum of 3 quarters · filed 2024-12-17 | $6.94M 10-K · filed 2024-12-17 |
| 2023-06-30 | $1.89M 10-Q · filed 2024-08-14 | $3.60M derived: sum of 2 quarters · filed 2024-08-14 | $5.16M 10-Q · filed 2024-08-14 | $6.60M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $1.71M 10-Q · filed 2024-05-14 | $3.27M 10-Q · filed 2024-05-14 | $4.71M derived: sum of 3 quarters · filed 2024-05-14 | $5.93M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $1.56M 10-Q · filed 2024-02-13 | $3.00M derived: sum of 2 quarters · filed 2024-02-13 | $4.23M derived: sum of 3 quarters · filed 2024-02-13 | $5.43M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-09-30 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-15 | $2.66M derived: sum of 2 quarters · filed 2023-12-15 | $3.87M derived: sum of 3 quarters · filed 2023-12-15 | $4.93M 10-K · filed 2023-12-15 |
| 2022-06-30 | $1.23M 10-Q · filed 2023-08-14 | $2.43M derived: sum of 2 quarters · filed 2023-08-14 | $3.49M 10-Q · filed 2023-08-14 | $4.50M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $1.21M 10-Q · filed 2023-05-12 | $2.27M 10-Q · filed 2023-05-12 | $3.27M derived: sum of 3 quarters · filed 2023-05-12 | $4.18M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $1.06M 10-Q · filed 2023-02-13 | $2.07M derived: sum of 2 quarters · filed 2023-02-13 | $2.97M derived: sum of 3 quarters · filed 2023-02-13 | $4.05M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-09-30 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-22 | $1.91M derived: sum of 2 quarters · filed 2022-12-22 | $2.99M derived: sum of 3 quarters · filed 2022-12-22 | $3.93M 10-K · filed 2022-12-22 |
| 2021-06-30 | $901.13K 10-Q · filed 2022-08-11 | $1.98M derived: sum of 2 quarters · filed 2022-08-11 | $2.92M 10-Q · filed 2022-08-11 | $3.70M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $1.08M 10-Q · filed 2022-05-12 | $2.02M 10-Q · filed 2022-05-12 | $2.80M derived: sum of 3 quarters · filed 2022-05-31 | $3.25M derived: sum of 4 quarters · filed 2022-05-31 |
| 2020-12-31 | $934.16K 10-Q · filed 2022-02-14 | $1.72M derived: sum of 2 quarters · filed 2022-05-31 | $2.17M derived: sum of 3 quarters · filed 2022-05-31 | $2.51M derived: sum of 4 quarters · filed 2022-05-31 |
| 2020-09-30 | $784.72K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-05-31 | $1.23M derived: sum of 2 quarters · filed 2022-05-31 | $1.57M derived: sum of 3 quarters · filed 2022-05-31 | $2.08M 10-K/A · filed 2022-05-31 |
| 2020-06-30 | $447.15K 10-Q · filed 2021-08-13 | $789.26K derived: sum of 2 quarters · filed 2021-08-13 | $1.29M 10-Q · filed 2021-08-13 | $1.75M derived: sum of 4 quarters · filed 2021-08-13 |
| 2020-03-31 | $342.10K 10-Q · filed 2021-05-14 | $843.92K 10-Q · filed 2021-05-14 | $1.30M derived: sum of 3 quarters · filed 2021-05-14 | $1.73M derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | $501.82K 10-Q · filed 2021-02-16 | $962.75K derived: sum of 2 quarters · filed 2021-02-16 | $1.39M derived: sum of 3 quarters · filed 2021-02-16 | $1.82M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-09-30 | $460.93K derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-09 | $883.71K derived: sum of 2 quarters · filed 2020-12-09 | $1.32M derived: sum of 3 quarters · filed 2020-12-09 | $1.53M 10-K · filed 2020-12-09 |
| 2019-06-30 | $422.78K 10-Q · filed 2020-08-13 | $859.09K derived: sum of 2 quarters · filed 2020-08-13 | $1.07M 10-Q · filed 2020-08-13 | $1.45M derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | $436.31K 10-Q · filed 2020-05-14 | $645.48K 10-Q · filed 2020-05-14 | $1.03M derived: sum of 3 quarters · filed 2020-05-14 | $1.26M derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $209.17K 10-Q · filed 2020-02-14 | $593.68K derived: sum of 2 quarters · filed 2020-02-14 | $819.21K derived: sum of 3 quarters · filed 2020-02-14 | $924.25K derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-09-30 | $384.51K derived: 10-K 9 month − 10-Q 6 month · filed 2019-12-20 | $610.04K derived: sum of 2 quarters · filed 2019-12-20 | $715.09K 10-K · filed 2019-12-20 | $950.01K derived: sum of 4 quarters · filed 2019-12-20 |
| 2018-06-30 | $225.53K 10-Q · filed 2019-08-14 | $330.57K 10-Q · filed 2018-08-13 | $565.50K 10-Q · filed 2019-08-14 | $837.15K derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $105.05K 10-Q · filed 2019-05-10 | $339.97K 10-Q · filed 2019-05-10 | $611.62K derived: sum of 3 quarters · filed 2019-05-10 | $768.34K derived: sum of 4 quarters · filed 2019-05-10 |
| 2017-12-31 | $234.93K 10-Q · filed 2019-02-14 | $506.58K derived: sum of 2 quarters · filed 2019-03-18 | $663.29K derived: sum of 3 quarters · filed 2019-03-18 | $735.33K 10-KT · filed 2019-03-18 |
| 2017-09-30 | $271.65K derived: 10-KT 9 month − 10-Q 6 month · filed 2019-03-18 | $428.37K derived: sum of 2 quarters · filed 2019-03-18 | $500.41K 10-KT · filed 2019-03-18 | |
| 2017-06-30 | $156.72K 10-Q · filed 2018-08-13 | $228.76K 10-Q · filed 2018-08-13 | ||
| 2017-03-31 | $72.04K 10-Q · filed 2018-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |